• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
TechCancer research

Everything You Need to Know About the White House’s Cancer Moonshot

By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
By
Hilary Brueck
Hilary Brueck
Down Arrow Button Icon
February 1, 2016, 4:12 PM ET
Preparations For The World Economic Forum (WEF) 2016
U.S. Vice President Joseph "Joe" Biden speaks during a panel session on cancer research, treatment and data science in Davos, Switzerland, on Tuesday, Jan. 19, 2016. World leaders, influential executives, bankers and policy makers attend the 46th annual meeting of the World Economic Forum in Davos from Jan. 20 - 23. Photographer: Jason Alden/Bloomberg *** Local Caption *** Joe BidenJason Alden—Bloomberg via Getty Images

The White House Cancer Moonshot Task Force had its first official meeting today, making clearer the details behind the initiative President Obama introduced in his annual State of the Union address last month.

Dubbed a “moonshot” without the trip to space, the sky-high effort is essentially a re-doubled cancer research push, aimed at accomplishing in the next five years what would normally take ten. Headed by Vice President Biden, the effort aims to better coordinate cancer lab research and clinical data from around the country—while cutting down on unnecessary bureaucracy.

The $1 billion initiative begins immediately with $195 million in funding for the National Institutes of Health this year. But President Obama’s proposed 2017 budget, which he’ll submit to Congress next week, would add $755 million to that sum next year for more cancer research at both the NIH and the FDA.

According to a Medium post written by Vice President Biden introducing the task force, some of the team’s top priorities include:

  • Speeding up access to cancer databases for doctors and researchers,
  • Opening up clinical trials, and
  • Applying the funding so that “some of the best work going on has the funding that it needs.”

Get Data Sheet, Coins2Day’stechnology newsletter.

So, what might 10 years of research packed into five look like? Some of the biggest cancer research breakthroughs in the past decade have included:

  • More than 60 FDA-approved anti-cancer drugs, with 14 approved in 2015,
  • A National Institutes of Health Cancer Genome Atlas that has sequenced tumor samples from 33 different types of cancer, and
  • A first-of-its-kind cancer vaccine that can prevent cervical cancer.

But as Coins2Day’s Clifton Leaf argues, much of what’s needed to boost today’s cancer research may be, like the trip to the moon, a question of building the right infrastructure. This would involve creating new tools for classifying and organizing cancer data and developing more streamlined systems for sharing research. But also, only 5% of today’s cancer patients are enrolled in clinical trials, and obstacles to participation will need to be reduced.

President Obama wants the U.S. To cure cancer:

As a father who lost his eldest son Beau to brain cancer last year, Biden’s fight is not all politics.

“I want you to know that I’ll be focusing the rest of the time I have in office — and the rest of my life — on this effort,” Biden wrote.

The task force’s first recommendations, set to be publicly available online, are due at the end of 2016.

On Feb. 2, this story was edited to note that the task force was not yet backed by $1 billion, but it would be if the President’s 2017 budget is approved.

About the Author
By Hilary Brueck
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.